Role for mTOR Signaling and Neuronal Activity in Morphine-Induced Adaptations in Ventral Tegmental Area Dopamine Neurons
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
SUMMARY While the abuse of opiate drugs continues to rise, the neuroadaptations that occur with long-term drug exposure remain poorly understood. We describe here a series of chronic morphine-induced adaptations in ventral tegmental area (VTA) dopamine neurons, which are mediated via downregulation of AKT-mTORC2 (mammalian target of rapamycin complex-2). Chronic opiates decrease the size of VTA dopamine neurons in rodents, an effect seen in humans as well, and concomitantly increase the excitability of the cells but decrease dopamine output to target regions. Chronic morphine decreases mTORC2 activity, and overexpression of Rictor, a component of mTORC2, prevents morphine-induced changes in cell morphology and activity. Further, local knock-out of Rictor in VTA decreases DA soma size and reduces rewarding responses to morphine, consistent with the hypothesis that these adaptations represent a mechanism of reward tolerance. Together, these findings demonstrate a novel role for AKT-mTORC2 signaling in mediating neuroadaptations to opiate drugs of abuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Homeostatic plasticity in the developing nervous system
Turrigiano, G. G., & Nelson, S. B. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1327 · Cited by 2,485
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 6×
“1 in VTA, which we showed decreases DA neuron firing rate (Krishnan et al., 2007).”
BackgroundMethodInfluentialSelf-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Self-citationSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Self-citationOpioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637 · cited 2×
“Opiates acutely activate VTA DA neurons by inhibiting their GABAergic input through hyperpolarization of local GABA interneurons (Johnson and North, 1992), and decreasing longterm potentiation of GABAergic synapses onto DA neurons (Niehaus et al.”
BackgroundThe nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294 · cited 3×
“These mechanisms may not be functionally distinct, as downregulation of IRS2 may also lead to decreased mTORC2 activity, consistent with the idea that phosphorylation of the two AKT sites occurs sequentially (Pearce et al., 2010; Oh and Jacinto, 2011).”
BackgroundExpression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine
Kelz, M. B., Chen, J., Carlezon, W. A., Whisler, K., Gilden, L., Beckmann, A. M., Steffen, C., Zhang, Y.-J., Marotti, L., Self, D. W., et al. (1999) · Nature · doi:10.1038/45790 · Cited by 641 · cited 1×
“Conditioned Place Preference Morphine conditioned place preference (CPP) was completed as described previously (Kelz et al., 1999).”
MethodSelf-citationLüscher, C., & Slesinger, P. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2834 · Cited by 617
Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5685-08.2009 · Cited by 441
Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats
Cheer, J. F., Wassum, K. M., Heien, M. L. A. V., Phillips, P. E. M., & Wightman, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-04.2004 · Cited by 343
Self-citationPothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · cited 14×
“The findings of reduced DA soma size and DA output are consistent with earlier reports that chronic morphine decreases levels of neurofilament proteins in VTA and impairs axoplasmic transport from VTA to NAc (Beitner-Johnson et al., 1992; Beitner-Johnson and Nestler, 1993).”
BackgroundInfluentialKrishnan, V., Han, M.-H., Mazei-Robison, M., Iñiguez, S. D., Ables, J. L., Vialou, V., Berton, O., Ghose, S., Covington, H. E., Wiley, M. D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.003 · Cited by 176 · cited 7×
“Western Blotting Tissue was collected and processed as described previously (Krishnan et al., 2008; Russo et al., 2007).”
BackgroundMethodResultSelf-citationDrugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area
Niehaus, J. L., Murali, M., & Kauer, J. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07256.x · Cited by 140
Ehninger, D., De Vries, P. J., & Silva, A. J. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01208.x · Cited by 120 · cited 1×
“Given recent evidence that increased mTORC1 signaling can contribute to neurological and neuropsychiatric conditions (Ehninger et al., 2009; Hoeffer and Klann, 2010; Hoeffer et al., 2008), it is important to investigate whether elevated mTORC1 activity plays a role in other effects of morphine.”
BackgroundCoque, L., Mukherjee, S., Cao, J.-L., Spencer, S., Marvin, M., Falcon, E., Sidor, M. M., Birnbaum, S. G., Graham, A., Neve, R. L., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.33 · Cited by 120 · cited 1×
“A similar phenomenon was recently described by Coque et al. (2011) in ClockD19 mice, which also exhibit decreased VTA DA soma size and increased DA firing rate.”
BackgroundSelf-citation
Research works printed but not linked: 37
- Beitner-Johnson, 1993, Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system, Neuroreport, 5, 57, 10.1097/00001756-199310000-00014 · DOI
- Beitner-Johnson, 1992, Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area, J. Neurosci., 12, 2165, 10.1523/JNEUROSCI.12-06-02165.1992 · DOI · Paper page
- Boulbes, 2010, Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2, Mol. Cancer Res., 8, 896, 10.1158/1541-7786.MCR-09-0409 · DOI · Paper page
- Cao, 2010, Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons, Proc. Natl. Acad. Sci. USA, 107, 17011, 10.1073/pnas.1010077107 · DOI · Paper page
- Chen, 2001, Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene, Genes Dev., 15, 2203, 10.1101/gad.913901 · DOI · Paper page
- Chu, 2007, Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats, Brain Res., 1182, 90, 10.1016/j.brainres.2007.08.086 · DOI
- Diana, 1995, Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats, J. Pharmacol. Exp. Ther., 272, 781, 10.1016/S0022-3565(25)24484-6 · DOI · Paper page
- Dibble, 2009, Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1, Mol. Cell. Biol., 29, 5657, 10.1128/MCB.00735-09 · DOI · Paper page
- Easton, 2005, Role for Akt3/protein kinase Bgamma in attainment of normal brain size, Mol. Cell. Biol., 25, 1869, 10.1128/MCB.25.5.1869-1878.2005 · DOI · Paper page
- Fischer, 2008, Morphine blood levels, dependence, and regulation of hippocampal subgranular zone proliferation rely on administration paradigm, Neuroscience, 151, 1217, 10.1016/j.neuroscience.2007.11.035 · DOI
- Foster, 2010, Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony, J. Biol. Chem., 285, 14071, 10.1074/jbc.R109.094003 · DOI · Paper page
- Georges, 2006, No effect of morphine on ventral tegmental dopamine neurons during withdrawal, J. Neurosci., 26, 5720, 10.1523/JNEUROSCI.5032-05.2006 · DOI · Paper page
- Hoeffer, 2010, mTOR signaling: at the crossroads of plasticity, memory and disease, Trends Neurosci., 33, 67, 10.1016/j.tins.2009.11.003 · DOI · Paper page
- Hoeffer, 2008, Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior, Neuron, 60, 832, 10.1016/j.neuron.2008.09.037 · DOI · Paper page
- Horvath, 2007, Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age, J. Neurosci., 27, 13371, 10.1523/JNEUROSCI.2398-07.2007 · DOI
- Hu, 2009, Electroacupuncture treatment reverses morphine-induced physiological changes in dopaminergic neurons within the ventral tegmental area, Addict. Biol., 14, 431, 10.1111/j.1369-1600.2009.00163.x · DOI
- Hyman, 2006, Neural mechanisms of addiction: the role of reward-related learning and memory, Annu. Rev. Neurosci., 29, 565, 10.1146/annurev.neuro.29.051605.113009 · DOI · Paper page
- Julien, 2010, mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling, Mol. Cell. Biol., 30, 908, 10.1128/MCB.00601-09 · DOI · Paper page
- Kwon, 2003, mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo, Proc. Natl. Acad. Sci. USA, 100, 12923, 10.1073/pnas.2132711100 · DOI · Paper page
- Laplante, 2009, mTOR signaling at a glance, J. Cell Sci., 122, 3589, 10.1242/jcs.051011 · DOI · Paper page
- McClung, 2005, Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area, J. Neurosci., 25, 6005, 10.1523/JNEUROSCI.0062-05.2005 · DOI · Paper page
- Oh, 2011, mTOR complex 2 signaling and functions, Cell Cycle, 10, 2305, 10.4161/cc.10.14.16586 · DOI · Paper page
- Partovian, 2008, Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells, Mol. Cell, 32, 140, 10.1016/j.molcel.2008.09.010 · DOI · Paper page
- Rossetti, 1992, Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats, Eur. J. Pharmacol., 221, 227, 10.1016/0014-2999(92)90706-A · DOI · Paper page
- Rossetti, 1992, Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence, Ann. N Y Acad. Sci., 654, 513, 10.1111/j.1749-6632.1992.tb26016.x · DOI
- Russo, 2007, IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates, Nat. Neurosci., 10, 93, 10.1038/nn1812 · DOI · Paper page
- Sarbassov, 2005, Growing roles for the mTOR pathway, Curr. Opin. Cell Biol., 17, 596, 10.1016/j.ceb.2005.09.009 · DOI · Paper page
- Shah, 2004, Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies, Curr. Biol., 14, 1650, 10.1016/j.cub.2004.08.026 · DOI · Paper page
- Shiota, 2006, Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability, Dev. Cell, 11, 583, 10.1016/j.devcel.2006.08.013 · DOI · Paper page
- Siuta, 2010, Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice, PLoS Biol., 8, e1000393, 10.1371/journal.pbio.1000393 · DOI · Paper page
- Sklair-Tavron, 1996, Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons, Proc. Natl. Acad. Sci. USA, 93, 11202, 10.1073/pnas.93.20.11202 · DOI · Paper page
- Spiga, 2010, Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence, Addict. Biol., 15, 266, 10.1111/j.1369-1600.2010.00218.x · DOI
- Spiga, 2003, Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy, Eur. J. Neurosci., 17, 605, 10.1046/j.1460-9568.2003.02435.x · DOI · Paper page
- Treins, 2010, Rictor is a novel target of p70 S6 kinase-1, Oncogene, 29, 1003, 10.1038/onc.2009.401 · DOI
- van Diepen, 2009, MyosinV controls PTEN function and neuronal cell size, Nat. Cell Biol., 11, 1191, 10.1038/ncb1961 · DOI · Paper page
- Wang, 2003, Control of synaptic strength, a novel function of Akt, Neuron, 38, 915, 10.1016/S0896-6273(03)00356-8 · DOI · Paper page
- Wolf, 1999, Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration, J. Neurochem., 73, 1520, 10.1046/j.1471-4159.1999.0731520.x · DOI · Paper page
Cited by
Epigenetic mechanisms of drug addiction
Nestler, E. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.004 · Cited by 454
Self-citationmTOR complexes in neurodevelopmental and neuropsychiatric disorders
Costa-Mattioli, M., & Monteggia, L. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3546 · Cited by 367
Molecular neurobiology of mTOR
Switon, K., Kotulska, K., Janusz-Kaminska, A., Zmorzynska, J., & Jaworski, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.017 · Cited by 387
mTOR in Brain Physiology and Pathologies
Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 356
mTORC2 controls actin polymerization required for consolidation of long-term memory
Huang, W., Zhu, P. J., Zhang, S., Zhou, H., Stoica, L., Galiano, M., Krnjević, K., Roman, G., & Costa-Mattioli, M. (2013) · Nature Neuroscience · doi:10.1038/nn.3351 · Cited by 307
Metadata
- Authors
- Mazei-Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M. A., Galli, A., Niswender, K. D., Appasani, R., Horvath, M. C., Neve, R. L., Worley, P. F., Snyder, S. H., Hurd, Y. L., Cheer, J. F., Han, M.-H., Russo, S. J., & Nestler, E. J.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 72
- Issue
- 6
- Pages
- 977-990
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2009097612
- Cited by
- 143
- References
- 17
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 594 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.